Pharma News

pSivida Corp. a leader in the development of sustained release drug products and technologies,  announced the Company’s second Phase 3 trial of Durasert three-year treatment for posterior segment uveitis achieved the trial’s primary endpoint. The study involved 153 patients and the primary endpoint was prevention of recurrence of posterior uveitis at six months with patients continuing to be followed for 36 months.

The Department of Pharmaceutical Products (DoP) has set up a GST facilitation center to enable pharmaceutical companies to successfully implement the new tax regime.

President Pranab Mukherjee lamented the lack of infrastructure and health personnel in the country, particularly in rural areas, and expressed hope that more investment would help bridge the gap.

The Center has asked the Indian Council for Medical Research (ICMR) to carry out a detailed study to assess whether there is any leaching of plastic bottles into the liquid medicine formulations stored in them.

The CSIR-Central Drugs Research Institute (CDRI) will inform Prime Minister Narendra Modi about three new drugs being developed by the Institute during its visit to the campus. Modi is also president of the Scientific and Industrial Research Council (CSIR) and this will be his first visit to any of his laboratories in the country. The institute is also organizing an exhibition to highlight the CDRI's contribution to the discovery and development of PM medications.

The health ministry is ready to deploy "Mission Parivar Vikas" in these districts to improve access to family planning services, raise awareness and make family planning options available. To achieve the goal of faster population control, the government has decided to accelerate family planning measures by identifying 146 districts where the total fertility rate (TFR, the number of children born per woman) is more than three, 28% of the population.

[adsense:336x280:8701650588]

In great relief for foreign tourists visiting India for medical and wellness travel, the government has decided to standardize the cost of such services in the country through a centralized web portal "The growth of medical tourism and wellness in the country has been between 23 and 25 percent in the country and there is a lot of potential here, so we have decided to standardize services in this sector," Tourism Minister Mahesh Sharma said.

Bhutan and the Maldives have eliminated measles, a highly infectious disease that is a major child killer worldwide. The two countries have become the first in the WHO South-East Asia region to be verified for having interrupted the endemic transmission of the measles virus, before the regional target of 2020.

The Intensified Diarrhea Control Fortnight (IDCF) has been launched by the Ministry of Health and Family Welfare in order to intensify efforts to reduce child mortality from diarrhea. The Ministry has made it a national priority to bring health outcomes among children to an equitable level with the rest of the world. Through this initiative, the Ministry will mobilize health workers, state governments and other stakeholders to prioritize investment in controlling diarrhea, one of the most common childhood diseases. Its goal is to create mass awareness about the most effective and low-cost diarrhea treatment, a combination of oral rehydration salt solution (ORS) and zinc tablets.

LEO Pharma announced that the first patients have been dosed in a phase 3 clinical study of tralokinumab. Tralokinumab is an investigational human monoclonal antibody that specifically targets the cytokine IL-131, which plays an important role in the development of moderate-to-severe atopic dermatitis2. Tralokinumab is not currently licensed in any indication.